NYSE: CSW
CSW INDUSTRIALS, INC.CIK 0001624794 · SIC 2891 · Adhesives & Sealants
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade CSW commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
CSW Industrials reports fiscal Q4 2026 results for quarter ended March 31, 2026
2 material changes detected. Sign up free to read the summary.
CSW: revenue $1.08B, net income $112.0M. CSW completes MARS Parts acquisition, exits Greco; organic sales decline 2.1%
5 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 30, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Income (Unaudited)
(Amounts in thousands, except per share amounts)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 |
|---|---|---|
| Revenues, net | 350,650 | 263,646 |
| Cost of revenues | (193,289) | (148,204) |
| Gross profit | 157,361 | 115,442 |
| Selling, general and administrative expenses | (77,507) | (60,566) |
| Operating income | 79,854 | 54,876 |
| Interest expense, net | (12,731) | (1,022) |
| Other income (loss), net | (220) | 528 |
| Income before income taxes | 66,903 | 54,382 |
| Provision for income taxes | (17,123) | (13,211) |
| Net income | 49,780 | 41,171 |
| Less: Income attributable to redeemable noncontrolling interest | (21) | (246) |
| Net income attributable to CSW | 49,759 | 40,925 |
| Net income per share attributable to CSW | ||
| Basic | 3.05 | 2.43 |
| Diluted | 3.04 | 2.43 |
| Weighted average number of shares outstanding: | ||
| Basic | 16,330 | 16,808 |
| Diluted | 16,365 | 16,863 |
Consolidated Balance Sheets (Unaudited)
(Amounts in thousands, except for per share amounts)
| Description | June 30, 2026 | March 31, 2026 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | 47,495 | 33,799 |
| Accounts receivable, net of allowance for expected credit losses of $2,426 and $2,314, respectively | 233,311 | 210,264 |
| Inventories, net | 305,202 | 309,707 |
| Prepaid expenses and other current assets | 20,005 | 26,555 |
| Assets held for sale | 9,948 | 8,742 |
| Total current assets | 615,961 | 589,067 |
| Property, plant and equipment, net of accumulated depreciation of $130,163 and $125,552, respectively | 107,332 | 107,536 |
| Goodwill | 640,273 | 632,631 |
| Intangible assets, net | 884,841 | 900,051 |
| Other assets | 85,212 | 87,399 |
| Total assets | 2,333,619 | 2,316,684 |
| LIABILITIES AND EQUITY | ||
| Current liabilities: | ||
| Accounts payable | 82,834 | 76,930 |
| Accrued and other current liabilities | 112,003 | 116,055 |
| Current portion of long-term debt | 29,458 | 29,458 |
| Liabilities held for sale | 3,831 | 4,478 |
| Total current liabilities | 228,126 | 226,921 |
| Long-term debt | 825,993 | 839,836 |
| Retirement benefits payable | 1,029 | 1,040 |
| Other long-term liabilities | 185,849 | 179,489 |
| Total liabilities | 1,240,997 | 1,247,286 |
| Commitments and contingencies (See Note 14) | ||
| Redeemable noncontrolling interest | 19,010 | 18,989 |
| Equity: | ||
| Common shares, $0.01 par value | 179 | 178 |
| Shares authorized – 50,000 | ||
| Shares issued – 17,946 and 17,893, respectively | ||
| Preferred shares, $0.01 par value | — | — |
| Shares authorized (10,000) and issued (0) | ||
| Additional paid-in capital | 528,168 | 520,076 |
| Treasury shares, at cost (1,645 and 1,544 shares, respectively) | (288,927) | (257,704) |
| Retained earnings | 843,785 | 798,956 |
| Accumulated other comprehensive loss | (9,593) | (11,097) |
| Total equity | 1,073,612 | 1,050,409 |
| Total liabilities, redeemable noncontrolling interest and equity | 2,333,619 | 2,316,684 |
Consolidated Statements of Cash Flows (Unaudited)
(Amounts in thousands)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net income | 49,780 | 41,171 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation | 4,626 | 3,929 |
| Amortization of acquisition-related intangible assets & inventory step-up | 15,633 | 9,411 |
| Amortization of deferred financing fees | 307 | 322 |
| Provision for inventory reserves | 1,751 | 242 |
| Provision for credit losses | 188 | 72 |
| Share-based compensation | 4,091 | 4,037 |
| Net loss on disposals of property, plant and equipment | 357 | — |
| Net pension benefit | 20 | 17 |
| Net deferred taxes | 852 | 790 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (24,625) | (7,788) |
| Inventories | 2,170 | 7,641 |
| Prepaid expenses and other current assets | 7,462 | 656 |
| Other assets | 8 | 43 |
| Accounts payable and other current liabilities | 12,521 | 6 |
| Retirement benefits payable and other liabilities | 479 | 92 |
| Net cash provided by operating activities | 75,620 | 60,641 |
| Cash flows from investing activities: | ||
| Capital expenditures | (6,004) | (2,904) |
| Proceeds from sale of assets | 12 | — |
| Cash paid for acquisitions, net of cash received | — | (323,814) |
| Net cash used in investing activities | (5,992) | (326,718) |
| Cash flows from financing activities: | ||
| Borrowings on line of credit | 59,859 | 135,000 |
| Repayments of line of credit | (66,337) | (40,000) |
| Repayments on Term Loan A | (7,500) | — |
| Payments of deferred loan costs | — | (2,835) |
| Purchase of treasury shares | (36,341) | (9,091) |
| Payments of contingent consideration | (113) | (113) |
| Dividends | (4,909) | (4,537) |
| Net cash (used in) provided by financing activities | (55,341) | 78,424 |
| Effect of exchange rate changes on cash and equivalents | (591) | (202) |
| Net change in cash and cash equivalents | 13,696 | (187,855) |
| Cash and cash equivalents, beginning of period | 33,799 | 225,845 |
| Cash and cash equivalents, end of period | 47,495 | 37,990 |
| Non-cash investing and financing activities: | ||
| Capital expenditures included in accounts payable and other current liabilities | 528 | 436 |
Amounts as printed on the EDGAR/iXBRL face — (Amounts in thousands, except per share amounts); (Amounts in thousands, except for per share amounts); (Amounts in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗